Single and combination treatment of Toxoplasma gondii infections with a bumped kinase inhibitor and artemisone in vitro and with artemiside in experimentally infected mice is a research paper published in Experimental Parasitology (2023). On theSindex it has a DataRank of 0.312. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.312
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →South African Medical Research Council
Grant: UID 129135
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Grant: 310030_214897
National Institutes of Health
Grant: R01AI155412
National Institutes of Health
Grant: R01HD102487
Swiss National Science Foundation
Grant: 214897
Going for unexplored territory: novel drugs and their targets in Toxoplasma and Neospora
Swiss National Science Foundation
Grant: 310030
National Institutes of Health
Grant: 5R01AI155412-05
Optimization of Lead BKIs for Cryptosporidiosis Therapy
National Institutes of Health
Grant: 5R01HD102487-05
Bumped-Kinase Inhibitor Drug Development for Toxoplasmosis
Medical Research Council
National Research Foundation
Uniscientia Foundation
FWCI
1.65
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals